Description
Ksefocam (Lornoxicam) Coated Tablets 8 mg. №10
Ingredients:
Each coated tablet contains 8 mg of lornoxicam as the active ingredient.
Mechanism of Action:
Lornoxicam, a nonsteroidal anti-inflammatory drug (NSAID), exerts its pharmacological effects by inhibiting the enzyme cyclooxygenase, leading to a reduction in prostaglandin synthesis. This action results in analgesic, anti-inflammatory, and antipyretic properties.
Pharmacological Properties:
Lornoxicam demonstrates potent anti-inflammatory, analgesic, and antipyretic activities by selectively inhibiting cyclooxygenase, thereby suppressing prostaglandin production responsible for pain and inflammation.
Indications for Use:
Ksefocam tablets are indicated for the management of pain and inflammation associated with conditions such as osteoarthritis and rheumatoid arthritis.
Contraindications:
Avoid the use of Ksefocam tablets in individuals with a history of hypersensitivity reactions to lornoxicam or other nonsteroidal anti-inflammatory drugs (NSAIDs).
Side Effects:
Common side effects of Ksefocam may include nausea, indigestion, and headache. Patients should consult a healthcare provider if these side effects persist or worsen.
Usage Instructions:
The recommended dosage of Ksefocam is one tablet daily, to be taken orally with a full glass of water. It is advised not to crush or chew the tablet.
Benefits Compared to Analogues:
Ksefocam offers the advantage of effective pain relief and anti-inflammatory action with a lower risk of gastrointestinal side effects compared to some traditional NSAIDs.
Suitable Patient Groups:
Ksefocam can be used in adult patients for the management of pain and inflammation. Dosage adjustments may be necessary for elderly individuals or those with renal impairment.
Storage and Shelf Life:
- Storage: Keep Ksefocam tablets at room temperature, protected from moisture and heat.
- Shelf Life: Check the expiration date on the packaging and do not use the product beyond that date.
Packaging Description:
Ksefocam tablets are supplied in blister packs containing 10 coated tablets. The packaging is designed to maintain the stability and integrity of the tablets.
